Mach-1 Financial Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Mach-1 Financial Group's BMY Position: Q1 2026 in Review
Mach-1 Financial Group sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 13,022 shares — an estimated $702K sold.
Mach-1 Financial Group first reported a position in BMY in Q4 2020 and held it in 8 quarters. The position peaked at $702K in Q4 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Mach-1 Financial Group reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- Mach-1 Financial Group sold 13,022 Bristol-Myers Squibb shares in Q1 2026, an estimated $702K.
- Mach-1 Financial Group first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 8 quarters.
- Mach-1 Financial Group's Bristol-Myers Squibb position peaked at $702K in Q4 2025.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Mach-1 Financial Group's 13F filing for Q1 2026, filed 13 May 2026.